title: Fetal outcomes after rituximab exposure in women with autoimmune vasculitis.
authors.affiliation: Joint Nephrology Fellowship Program, Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH), , Boston, Massachusetts, USA.
authors.forename: William F
authors.initials: WF
authors.lastname: Pendergraft
authors.forename: Martina M
authors.initials: MM
authors.lastname: McGrath
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Murphy
authors.forename: Patrick
authors.initials: P
authors.lastname: Murphy
authors.forename: Karen A
authors.initials: KA
authors.lastname: Laliberte
authors.forename: Michael F
authors.initials: MF
authors.lastname: Greene
authors.forename: John L
authors.initials: JL
authors.lastname: Niles
mesh_terms: D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D012189:Retrospective Studies; D000069283:Rituximab; D014657:Vasculitis / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab
keywords: Autoimmunity; B cells; Systemic vasculitis